Niacin has long been used to support good cardiovascular health. It has been proven effective at helping to maintain already normal levels of cholesterol.

The side effects of high amounts of niacin that may occur range from flushing and itching to liver toxicity and impaired glucose tolerance. Therefore, the need for a safer approach to niacin supplementation resulted in the investigation of niacin esters. One of the most widely studied niacin esters is inositol hexaniacinate (IHN). In numerous trials IHN has been found to be virtually free of the side effects associated with conventional niacin therapy. Pharmacokinetic studies show the IHN molecule is absorbed intact and slowly hydrolyzed in the bloodstream, releasing free niacin and inositol and having a diminished impact on the liver. Maximum serum levels are reached approximately 10 hours after ingestion, thus allowing for a more delayed release of niacin that reduces the risk of flushing.

A review of the literature reveals numerous positive studies on the use of IHN to support good circulatory health, particularly the support of vascular circulation to the extremities.

GUNA®-FGF 30 ml 0 Review(s) $43.00 CarbXzyme™ 120 Capsules 0 Review(s) $42.00 E-400 - 250 Softgels 0 Review(s) $43.60

Average Rating [short_review] [long_review] Reviewed by: [user_name] from [user_city]. [user_email] on [review_date]

1 capsule

Serving Size:1 capsule

Suggested Use: Take 1 capsule one to three times daily or as recommended by a health-care practitioner.

ALLERGY WARNING: This product is contraindicated in an individual with a history of hypersensitivity to any of its ingredients.